Literature DB >> 22058020

Buffered memory: a hypothesis for the maintenance of functional, virus-specific CD8(+) T cells during cytomegalovirus infection.

Christopher M Snyder1.   

Abstract

Chronic infections have been a major topic of investigation in recent years, but the mechanisms that dictate whether or not a pathogen is successfully controlled are incompletely understood. Cytomegalovirus (CMV) is a herpesvirus that establishes a persistent infection in the majority of people in the world. Like other herpesviruses, CMV is well controlled by an effective immune response and induces little, if any, pathology in healthy individuals. However, controlling CMV requires continuous immune surveillance, and thus, CMV is a significant cause of morbidity and death in immune-compromised individuals. T cells in particular play an important role in controlling CMV and both CD4(+) and CD8(+) CMV-specific T cells are essential. These virus-specific T cells persist in exceptionally large numbers during the infection, traffic into peripheral tissues and remain functional, making CMV an attractive vaccine vector for driving "CMV-like" T cell responses against recombinant antigens of choice. However, the mechanisms by which these T cells persist and differentiate while remaining functional are still poorly understood, and we have no means to promote their development in immune-compromised patients at risk for CMV disease. In this review, I will briefly summarize our current knowledge of CMV-specific CD8(+) T cells and propose a mechanism that may explain their maintenance and preservation of function during chronic infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22058020     DOI: 10.1007/s12026-011-8251-9

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  81 in total

1.  The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines.

Authors:  Laila E Gamadia; Ester M M van Leeuwen; Ester B M Remmerswaal; Si-La Yong; Sugianto Surachno; Pauline M E Wertheim-van Dillen; Ineke J M Ten Berge; René A W Van Lier
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 2.  Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal.

Authors:  Michael A Jarvis; Jay A Nelson
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

3.  Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.

Authors:  Emanuela M Iancu; Patricia Corthesy; Petra Baumgaertner; Estelle Devevre; Verena Voelter; Pedro Romero; Daniel E Speiser; Nathalie Rufer
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

4.  PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy.

Authors:  U Sester; D Presser; J Dirks; B C Gärtner; H Köhler; M Sester
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

5.  Viral infections induce abundant numbers of senescent CD8 T cells.

Authors:  D Voehringer; C Blaser; P Brawand; D H Raulet; T Hanke; H Pircher
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

6.  Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection.

Authors:  Ester M M van Leeuwen; Ester B M Remmerswaal; Mireille T M Vossen; Ajda T Rowshani; Pauline M E Wertheim-van Dillen; René A W van Lier; Ineke J M ten Berge
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

7.  Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1).

Authors:  David Voehringer; Marie Koschella; Hanspeter Pircher
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

8.  Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus.

Authors:  Christopher M Snyder; Kathy S Cho; Elizabeth L Bonnett; Jane E Allan; Ann B Hill
Journal:  PLoS Pathog       Date:  2011-10-06       Impact factor: 6.823

9.  Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates.

Authors:  Surojit Sarkar; Vandana Kalia; W Nicholas Haining; Bogumila T Konieczny; Shruti Subramaniam; Rafi Ahmed
Journal:  J Exp Med       Date:  2008-03-03       Impact factor: 14.307

10.  Mature CD8(+) T lymphocyte response to viral infection during fetal life.

Authors:  Arnaud Marchant; Victor Appay; Marianne Van Der Sande; Nicolas Dulphy; Corinne Liesnard; Michael Kidd; Steve Kaye; Olubukola Ojuola; Geraldine M A Gillespie; Ana L Vargas Cuero; Vincenzo Cerundolo; Margaret Callan; Keith P W J McAdam; Sarah L Rowland-Jones; Catherine Donner; Andrew J McMichael; Hilton Whittle
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more
  20 in total

Review 1.  The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Miriam Ciáurriz; Amaya Zabalza; Lorea Beloki; Cristina Mansilla; Estela Pérez-Valderrama; Mercedes Lachén; Eva Bandrés; Eduardo Olavarría; Natalia Ramírez
Journal:  Cell Mol Life Sci       Date:  2015-07-15       Impact factor: 9.261

2.  Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.

Authors:  Zeguang Wu; Giada Frascaroli; Carina Bayer; Tatjana Schmal; Thomas Mertens
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

3.  Clonal evolution of CD8+ T cell responses against latent viruses: relationship among phenotype, localization, and function.

Authors:  Ester B M Remmerswaal; Paul L Klarenbeek; Nuno L Alves; Marieke E Doorenspleet; Barbera D C van Schaik; Rebecca E E Esveldt; Mirza M Idu; Ester M M van Leeuwen; Nelly van der Bom-Baylon; Antoine H C van Kampen; Sven D Koch; Hanspeter Pircher; Frederike J Bemelman; Anja Ten Brinke; Frank Baas; Ineke J M Ten Berge; Rene A W van Lier; Niek de Vries
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

4.  Differentiation and Protective Capacity of Virus-Specific CD8+ T Cells Suggest Murine Norovirus Persistence in an Immune-Privileged Enteric Niche.

Authors:  Vesselin T Tomov; Olesya Palko; Chi Wai Lau; Ajinkya Pattekar; Yuhang Sun; Ralitza Tacheva; Bertram Bengsch; Sasikanth Manne; Gabriela L Cosma; Laurence C Eisenlohr; Timothy J Nice; Herbert W Virgin; E John Wherry
Journal:  Immunity       Date:  2017-10-11       Impact factor: 31.745

5.  Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.

Authors:  Holly Turula; Mayank Tandon; Michael Quinn; Berthony Deslouches; Toktam Moghbeli; Christopher M Snyder
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

6.  T Cells in the Female Reproductive Tract Can Both Block and Facilitate HIV Transmission.

Authors:  Christopher J Miller; Ronald S Veazey
Journal:  Curr Immunol Rev       Date:  2019

Review 7.  T cell responses to cytomegalovirus.

Authors:  Paul Klenerman; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2016-04-25       Impact factor: 53.106

Review 8.  Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions.

Authors:  Niels A W Lemmermann; Annette Fink; Jürgen Podlech; Stefan Ebert; Vanessa Wilhelmi; Verena Böhm; Rafaela Holtappels; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2012-09-09       Impact factor: 3.402

Review 9.  T cell responses to viral infections - opportunities for Peptide vaccination.

Authors:  Sietske Rosendahl Huber; Josine van Beek; Jørgen de Jonge; Willem Luytjes; Debbie van Baarle
Journal:  Front Immunol       Date:  2014-04-16       Impact factor: 7.561

Review 10.  T cell memory in the context of persistent herpes viral infections.

Authors:  Nicole Torti; Annette Oxenius
Journal:  Viruses       Date:  2012-07-20       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.